VRTX Vertex Pharmaceuticals455.61+6.99 (+1.6%)
VRTX Vertex Pharmaceuticals456.40-1.65 (-0.4%)
VRTX Vertex Pharmaceuticals494.89+34.02 (+7.4%)
After Hours Gainer
VRTX Vertex Pharmaceuticals460.87+4.18+0.9%
After Hours:482.46+21.59 (+4.7%)
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
Business WireMon, 9-Mar 4:02 PM
After Hours:494.94+34.07 (+7.4%)
VRTX Vertex Pharmaceuticals496.98+31.96 (+6.9%)
